MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
Clinical trial NCT07574047 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07574047
- Sponsor
- Swiss Cancer Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2030-06-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.